Photo of Samuel Blackman taken from Day One Biopharmaceuticals/LinkedIn
Feb 26, 2024, 11:23
Samuel Blackman shares the Day One journey to reshape pediatric cancer drug development – Day One Biopharmaceuticals
Day One Biopharmaceuticals shared on their LinkedIn:
“Head of R&D and co-founder Samuel Blackman shares the Day One journey to reshape pediatric cancer drug development in this article for the Pediatric Cancer Research Foundation’s Profectus blog, Turning ‘One Day’ into ‘Day One’.”
Proceed to the article.
Source: Day One Biopharmaceuticals/LinkedIn
Aug 29, 2024, 20:47